Notice of Intent to Sole Source.pdf
PDF 156 KB Posted
- Attached to
- ClonoSEQ Reference Testing Service
- Solicitation number
- W81K00-25-Q-A045
- Issued by
-
Department of the Army Medical Command
About this file
This document is a Notice of Intent to Sole Source for ClonoSEQ FDA-cleared in vitro diagnostic (IVD) Testing Services issued by the Medical Readiness Contracting Office-West at Fort Sam Houston, TX. The contract will be awarded to Adaptive Biotechnologies Corporation for a 12-month base year with four 12-month option periods, utilizing FAR Part 13 Simplified Acquisition Procedures.
The solicitation (W81K00-25-Q-A045) covers 75 total ClonoSEQ assessments (15 per period) involving next-generation sequencing (NGS) genomic sequence analysis using multiplex PCR. The procurement is an all-or-none, brand name only acquisition with lowest price/technically acceptable evaluation criteria. Interested parties who believe they can provide similar services are encouraged to submit a written response to Colleen M. Rye by Friday, March 14, 2025 at 12:00 PM CST. The contract is associated with the Department of the Army Medical Command, with a NAICS code of 621511 (Medical Laboratories) and PSC code Q301 (Medical Laboratory Testing).
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
The Medical Readiness Contracting Office-West, located at Fort Sam Houston, TX intends to award a sole source firm fixed contract to Adaptive Biotechnologies Corporation, for a 12-month Base year and four (4) 12-month option periods for brand name ClonoSEQ FDA-cleared in vitro diagnostic (IVD) Testing Services. This notice of intent is not a request for competitive quotations. The acquisition will be conducted through FAR Part 13, Simplified Acquisition Procedures.
CLIN Description Quantity Unit of Measure clonoSEQ assessments (NGS ID and MRD) genomic sequence analysis using multiplex (PCR) 15 Each clonoSEQ assessments (NGS ID and MRD) genomic sequence analysis using multiplex (PCR) 15 Each clonoSEQ assessments (NGS ID and MRD) genomic sequence analysis using multiplex (PCR) 15 Each clonoSEQ assessments (NGS ID and MRD) genomic sequence analysis using multiplex (PCR) 15 Each clonoSEQ assessments (NGS ID and MRD) genomic sequence analysis using multiplex (PCR) 15 Each
The NAICS Code is 621511 Medical Laboratories
The PSC Code is Q301 Medical Laboratory Testing
As this is not a request for competitive quotes, the Government encourages all interested parties who believe they can provide the products/services to contact Colleen M. Rye via email at colleen.m.rye.civ@health.mil by Friday, 14 March 2025 by 12:00PM, CST and reference number W81K00-25-Q-A045 and submit a written response describing their ability to provide the product/services. Telephone calls are not authorized.
Basis of Award: Award will be based on lowest price/technically acceptable. Award is ALL or NONE/BRAND NAME ONLY.
A determination by the Government not to compete this proposed contract acquisition based upon responses to the notice is solely within the discretion of the Government.
Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.
File details come from the government source that posted it. Updated .